Liarozole

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Liarozole
Liarozole.svg
Names
IUPAC name
6-[(3-Chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole
Identifiers
3D model (Jmol)
ChemSpider
Properties
C17H13ClN4
Molar mass 308.77 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Liarozole is a retinoic acid metabolism-inhibiting chemical.[1]

Synthesis[edit]

Liarozole synthesis from Lednicer book 6 (Drugs of the Future citation).

References[edit]

  1. ^ Vahlquist, A; Blockhuys, S; Steijlen, P; Van Rossem, K; Didona, B; Blanco, D; Traupe, H (2013). "Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial". The British journal of dermatology. 170 (1): 173–81. doi:10.1111/bjd.12626. PMID 24102348.